According to the company statement referenced in the post, Moderna is developing a vaccine candidate targeting hantavirus, a disease-causing virus group that can lead to severe illness.
Moderna said it is working to create a hantavirus vaccine, according to the source text. The post provides no additional details on the vaccine program, such as development stage, timeline, clinical trial status, target geography, or regulatory pathway. Hantavirus refers to a group of viruses that can cause serious disease in humans, and vaccine development typically involves preclinical research followed by phased clinical testing and review by health regulators before any approval.